American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and …

K Cusi, S Isaacs, D Barb, R Basu, S Caprio… - Endocrine Practice, 2022 - Elsevier
Objective To provide evidence-based recommendations regarding the diagnosis and
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …

Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome

X Qu, R Donnelly - International journal of molecular sciences, 2020 - mdpi.com
Human sex hormone-binding globulin (SHBG) is a glycoprotein produced by the liver that
binds sex steroids with high affinity and specificity. Clinical observations and reports in the …

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

ME Rinella, BA Neuschwander-Tetri, MS Siddiqui… - Hepatology, 2023 - journals.lww.com
Abbreviations: AASLD, American Association for the Study of Liver Diseases; AI, artificial
intelligence; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUROC …

[HTML][HTML] KASL clinical practice guidelines: management of nonalcoholic fatty liver disease

SH Kang, HW Lee, JJ Yoo, Y Cho, SU Kim… - Clinical and …, 2021 - ncbi.nlm.nih.gov
The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …

A clinical overview of non‐alcoholic fatty liver disease: a guide to diagnosis, the clinical features, and complications—what the non‐specialist needs to know

MD Muthiah, N Cheng Han… - Diabetes, Obesity and …, 2022 - Wiley Online Library
Non‐alcoholic fatty liver disease (NAFLD) has a rapidly rising prevalence worldwide and is
the most common cause of liver disease in developed countries. In this article, we discuss …

[HTML][HTML] Beyond fertility: polycystic ovary syndrome and long-term health

LG Cooney, A Dokras - Fertility and sterility, 2018 - Elsevier
Polycystic ovary syndrome (PCOS) is a reproductive, endocrine, and metabolic disorder
affecting millions of women worldwide. Women with PCOS are often identified in …

Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study

A Subramanian, A Anand, NJ Adderley… - European journal of …, 2021 - academic.oup.com
Objective Several recent observational studies have linked metabolic comorbidities to an
increased risk from COVID-19. Here we investigated whether women with PCOS are at an …

Hepatic sexual dimorphism—implications for non-alcoholic fatty liver disease

P Lefebvre, B Staels - Nature Reviews Endocrinology, 2021 - nature.com
The liver is often thought of as a single functional unit, but both its structural and functional
architecture make it highly multivalent and adaptable. In any given physiological situation …

Approach to androgen excess in women: Clinical and biochemical insights

L Cussen, T McDonnell, G Bennett… - Clinical …, 2022 - Wiley Online Library
Androgen excess in women typically presents clinically with hirsutism, acne or androgenic
alopecia. In the vast majority of cases, the underlying aetiology is polycystic ovary syndrome …

The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome

D Liu, X Gao, XF Pan, T Zhou, C Zhu, F Li, JG Fan… - BMC medicine, 2023 - Springer
Background Recent studies found associations between non-alcoholic fatty liver disease
(NAFLD) and polycystic ovary syndrome (PCOS), but the causal nature of this association is …